Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026
Rhea-AI Summary
Alpha Teknova (Nasdaq: TKNO) will report its financial results for the second quarter ended June 30, 2026, on Wednesday, August 5, 2026, after the market close. The company will host a webcast and conference call the same day at 6:00 p.m. Eastern Time, accessible via the Investor Relations section of its website, with a replay available about two hours later.
Positive
- None.
Negative
- None.
News Market Reaction – TKNO
In the Jul 23 session, TKNO declined 0.76%, reflecting a mild negative market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 22 | Earnings date | Neutral | -5.9% | Scheduled Q1 2026 results after market close with a 6:00 p.m. call |
| Feb 05 | Earnings date | Neutral | -2.2% | Scheduled Q4 and FY2025 results after market close with a 5:30 p.m. call |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
TKNO's two prior earnings-date announcements were followed by negative 24-hour reactions, diverging from the current pre-headline gain.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOLLISTER, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2026, on Wednesday, August 5, 2026, following the close of market.
Teknova will host a webcast and conference call on Wednesday, August 5, 2026, beginning at 6:00 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in genomics, molecular diagnostics, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture and cryopreservation media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.
Investor Contact
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100
Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259
This press release was published by a CLEAR® Verified individual.
